What does CUSIP 04746L104 represent in this 13F holders report?

CUSIP 04746L104 is the security identifier for ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value used to aggregate holder disclosures.

How many institutions held ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value in Q2 2022?

89 institutional investors reported ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value for Q2 2022. Use the holders table for investor-level position and value details.

Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA)

CUSIP: 04746L104

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, $0.0001 Par Value
Shares outstanding: 9,614,000
Total 13F shares: 21,955,517
Share change: -3,931,503
Total reported value: $66,960,232
Put/Call ratio: 31%
Price per share: $3.05
Number of holders: 89
Value change: -$100,026,928
Number of buys: 57
Number of sells: 44

Quarterly Holders Quick Answers

What is CUSIP 04746L104?
CUSIP 04746L104 identifies ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 04746L104:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PERCEPTIVE ADVISORS LLC	13F	Company	36%	3,425,916	$46,250,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	25%	2,415,102	$32,604,000	—	31 Mar 2022	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.1%	10,000	$26,964,000	—	31 Mar 2022	13F
FRANKLIN RESOURCES INC	13F	Company	20%	1,967,110	$26,556,000	—	31 Mar 2022	13F
RTW INVESTMENTS, LP	13F	Company	20%	1,906,557	$25,739,000	—	31 Mar 2022	13F
PATHSTONE FAMILY OFFICE, LLC	13F	Company	17%	1,629,540	$22,000,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	16%	1,511,078	$20,400,000	—	31 Mar 2022	13F
WASATCH ADVISORS LP	13F	Company	13%	1,274,791	$17,210,000	—	31 Mar 2022	13F
VR Adviser, LLC	13F	Company	10%	1,000,000	$13,500,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	8.6%	827,574	$11,172,000	—	31 Mar 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	8.4%	806,367	$10,886,000	—	31 Mar 2022	13F
Point72 Asset Management, L.P.	13F	Company	8%	768,100	$10,369,000	—	31 Mar 2022	13F
Bristlecone Advisors, LLC	13F	Company	7.9%	761,563	$10,281,000	—	31 Mar 2022	13F
Logos Global Management LP	13F	Company	7.5%	717,285	$9,683,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	7.3%	700,887	$9,462,000	—	31 Mar 2022	13F
AMERIPRISE FINANCIAL INC	13F	Company	6.1%	584,550	$7,892,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	5.9%	563,037	$7,600,000	—	31 Mar 2022	13F
Rock Springs Capital Management LP	13F	Company	5.7%	552,252	$7,455,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	3.7%	358,742	$4,843,000	—	31 Mar 2022	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	3.5%	339,468	$4,583,000	—	31 Mar 2022	13F
Hudson Bay Capital Management LP	13F	Company	3.5%	335,000	$4,523,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	2.9%	276,372	$3,731,000	—	31 Mar 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	2.5%	244,840	$3,305,000	—	31 Mar 2022	13F
Michael F. Price	13F	Individual	2.1%	200,000	$2,700,000	—	31 Mar 2022	13F
Woodline Partners LP	13F	Company	2.1%	197,589	$2,667,000	—	31 Mar 2022	13F
DAFNA Capital Management LLC	13F	Company	1.7%	160,983	$2,173,000	—	31 Mar 2022	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	1.5%	140,030	$1,890,000	—	31 Mar 2022	13F
OSAIC HOLDINGS, INC.	13F	Company	1.4%	134,519	$1,817,000	—	31 Mar 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.2%	115,900	$1,565,000	—	31 Mar 2022	13F
Walleye Capital LLC	13F	Company	1.1%	105,723	$1,427,000	—	31 Mar 2022	13F
GROUP ONE TRADING LLC	13F	Company	1.1%	105,236	$1,421,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	1.1%	104,818	$1,415,000	—	31 Mar 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1%	100,000	$1,350,000	—	31 Mar 2022	13F
Monashee Investment Management LLC	13F	Company	1%	100,000	$1,350,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	1.2%	115,382	$1,232,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.89%	85,397	$1,153,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.84%	80,341	$1,084,000	—	31 Mar 2022	13F
Laird Norton Wetherby Trust Company, LLC	13F	Company	0.83%	80,000	$1,080,000	—	31 Mar 2022	13F
DLD Asset Management, LP	13F	Company	0.78%	75,000	$1,012,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.72%	68,792	$929,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.71%	68,257	$921,000	—	31 Mar 2022	13F
BARCLAYS PLC	13F	Company	0.64%	61,118	$826,000	—	31 Mar 2022	13F
SIMPLEX TRADING, LLC	13F	Company	0.61%	58,531	$790,000	—	31 Mar 2022	13F
UBS Group AG	13F	Company	0.59%	56,315	$760,000	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.54%	52,200	$705,000	—	31 Mar 2022	13F
IEQ CAPITAL, LLC	13F	Company	0.52%	49,922	$674,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.51%	48,761	$658,000	—	31 Mar 2022	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.5%	47,954	$647,000	—	31 Mar 2022	13F
J. Goldman & Co LP	13F	Company	0.49%	47,450	$641,000	—	31 Mar 2022	13F
Belvedere Trading LLC	13F	Company	0.53%	51,098	$593,000	—	31 Mar 2022	13F

Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q2 2022

As of 30 Jun 2022, Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by 89 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,955,517 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., PATHSTONE FAMILY OFFICE, LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, STATE STREET CORP, CITADEL ADVISORS LLC, Bristlecone Advisors, LLC, and GOLDMAN SACHS GROUP INC. This page lists 89 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

-10

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.